Autopsy report · NCT01807286

Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis

“Sponsor requested termination”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 2 years 1 month before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

M.D. Anderson Cancer Center

Sponsor type

University, hospital or other

Conditions

Myeloma

Interventions

Pomalidomide; Melphalan; Dexamethasone; Questionnaires

Participants

3

Sites

1

Countries

United States

Trials that died the same way

• Evaluation of Cranioplasty Using Native Bone Autograft Versus Synthetic Bone Allograft
  “Sponsor termination” (95% match in meaning)
• A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors
  “The sponsor voluntarily requested termination” (94% match in meaning)
• A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
  “Terminated by sponsor” (90% match in meaning)
• ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
  “Terminated - Sponsor Decision” (89% match in meaning)
• Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
  “Sponsor Terminated” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.